IL-6 as a drug discovery target
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 3 (5) , 202-213
- https://doi.org/10.1016/s1359-6446(97)01164-1
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Paget's disease and osteoclast biologyBone, 1996
- Tissue-specific Isoforms of Chicken Myomesin Are Generated by Alternative SplicingPublished by Elsevier ,1996
- Myocardial Infarction in Myxoma Patients with Normal Coronary ArteriesAngiology, 1996
- A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal womenJournal of Bone and Mineral Research, 1996
- Evidence for Bioeffects of LY 139478 on the Human Preosteoclastic Cell Line FLG 29.1Biochemical and Biophysical Research Communications, 1995
- In vitro effects of interleukins on human mesangial cells: Implications for glomerulonephritisThe Journal of Pathology, 1995
- Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel diseaseDigestive Diseases and Sciences, 1992
- Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brainNeuroscience Letters, 1992
- Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.Journal of Clinical Investigation, 1990
- Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSFInternational Journal of Cancer, 1990